These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 25451695)
1. Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer. Fleming ND; Frumovitz M; Schmeler KM; dos Reis R; Munsell MF; Eifel PJ; Soliman PT; Nick AM; Westin SN; Ramirez PT Gynecol Oncol; 2015 Jan; 136(1):48-53. PubMed ID: 25451695 [TBL] [Abstract][Full Text] [Related]
2. The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy. Aslan K; Meydanli MM; Oz M; Tohma YA; Haberal A; Ayhan A J Gynecol Oncol; 2020 Jan; 31(1):e1. PubMed ID: 31788991 [TBL] [Abstract][Full Text] [Related]
3. Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy. Kim SI; Kim TH; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Kim JW; Park NH; Song YS Yonsei Med J; 2021 Mar; 62(3):231-239. PubMed ID: 33635013 [TBL] [Abstract][Full Text] [Related]
4. Predictive value of number of metastatic lymph nodes and lymph node ratio for prognosis of patients with FIGO 2018 stage IIICp cervical cancer: a multi-center retrospective study. Ye Y; Lian R; Li Z; Chen X; Huang Y; Yao J; Lu A; Lang J; Liu P; Chen C BMC Cancer; 2024 Aug; 24(1):1005. PubMed ID: 39138415 [TBL] [Abstract][Full Text] [Related]
5. Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients. Tsuruga T; Fujimoto A; Kawana K; Mori M; Hasumi Y; Kino N; Tomio K; Miura S; Tanikawa M; Sone K; Miyamoto Y; Ikeda Y; Kojima S; Adachi K; Nagasaka K; Matsumoto Y; Arimoto T; Oda K; Nakagawa S; Horie K; Yasugi T; Yokota H; Osuga Y; Fujii T Int J Clin Oncol; 2016 Apr; 21(2):359-366. PubMed ID: 26438230 [TBL] [Abstract][Full Text] [Related]
6. Prognostic analysis of patients with stage IIIC1p cervical cancer treated by surgery. Fan X; Wang Y; Yang N; Zhu P World J Surg Oncol; 2023 Jun; 21(1):186. PubMed ID: 37344912 [TBL] [Abstract][Full Text] [Related]
7. Lymph Node Ratio Can Better Predict Prognosis than Absolute Number of Positive Lymph Nodes in Operable Cervical Carcinoma. Widschwendter P; Polasik A; Janni W; de Gregorio A; Friedl TWP; de Gregorio N Oncol Res Treat; 2020; 43(3):87-95. PubMed ID: 31935729 [TBL] [Abstract][Full Text] [Related]
8. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma]. Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327 [No Abstract] [Full Text] [Related]
9. Number of Removed Pelvic Lymph Nodes as a Prognostic Marker in FIGO Stage IB1 Cervical Cancer with Negative Lymph Nodes. Wang R; Tao X; Wu X; Jiang H; Xia H J Minim Invasive Gynecol; 2020; 27(4):946-952. PubMed ID: 31394263 [TBL] [Abstract][Full Text] [Related]
10. Para-aortic and pelvic lymphadenectomy in locally advanced cervical cancer with pelvic lymph node metastasis. Jiang W; Zhong ML; Wang SL; Chen Y; Wang YN; Zeng SY; Liang MR World J Surg Oncol; 2024 Sep; 22(1):262. PubMed ID: 39350212 [TBL] [Abstract][Full Text] [Related]
11. Burden of lymphatic disease predicts efficacy of adjuvant radiation and chemotherapy in FIGO 2018 stage IIICp cervical cancer. Bogani G; Vinti D; Murgia F; Chiappa V; Leone Roberti Maggiore U; Martinelli F; Ditto A; Raspagliesi F Int J Gynecol Cancer; 2019 Nov; 29(9):1355-1360. PubMed ID: 31422352 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of lymph node ratio in patients with non-metastatic cervical cancer treated with radical hysterectomy: A population-based study. Ke Y; Zhang Z; Li Y; Qin Y; Yang Q; Zheng C Eur J Surg Oncol; 2024 Apr; 50(4):108258. PubMed ID: 38484490 [TBL] [Abstract][Full Text] [Related]
13. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study]. Wang W; Shang C; Huang J; Chen S; Shen H; Yao S Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of lymph node ratio in node-positive cervical cancer patients. Joo JH; Kim YS; Nam JH Medicine (Baltimore); 2018 Jul; 97(30):e11711. PubMed ID: 30045335 [TBL] [Abstract][Full Text] [Related]
15. Influence of lymph vascular space invasion on prognosis of patients with early-stage cervical squamous cell carcinoma. Yan M; Zhang YN; He JH; Sun JR; Sun XM Chin J Cancer; 2010 Apr; 29(4):425-30. PubMed ID: 20346220 [TBL] [Abstract][Full Text] [Related]
16. Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy. Xia X; Xu H; Wang Z; Liu R; Hu T; Li S Am J Clin Oncol; 2016 Dec; 39(6):604-608. PubMed ID: 24937635 [TBL] [Abstract][Full Text] [Related]
17. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma. Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408 [TBL] [Abstract][Full Text] [Related]
18. The prognostic value of the number of positive lymph nodes and the lymph node ratio in early-stage cervical cancer. Olthof EP; Mom CH; Snijders MLH; Wenzel HHB; van der Velden J; van der Aa MA Acta Obstet Gynecol Scand; 2022 May; 101(5):550-557. PubMed ID: 35218205 [TBL] [Abstract][Full Text] [Related]
19. Isolated para-aortic lymph node metastasis in FIGO stage IA2-IB2 carcinoma of the cervix: Revisiting the role of surgical assessment. Del Carmen MG; Pareja R; Melamed A; Rodriguez J; Greer A; Clark RM; Rice LW Gynecol Oncol; 2018 Sep; 150(3):406-411. PubMed ID: 30017539 [TBL] [Abstract][Full Text] [Related]
20. Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer. Fleming ND; Soliman PT; Westin SN; dos Reis R; Munsell M; Klopp AH; Frumovitz M; Nick AM; Schmeler K; Ramirez PT Int J Gynecol Cancer; 2015 Oct; 25(8):1437-44. PubMed ID: 26332387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]